Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

🌿

Herb

→

→

→

→

🧪

Evidence

23,295

trials · metas · refs

Plus 6,743 TCM formulas connecting herbs together

Subject Type: 🌿 Herbs ⚗️ Ingredients 📜 Formulas 🧬 Targets 🏥 Diseases

Quick picks: Taxol Oxytocin Morphine (?)-nicotine Testosterone Melatonin Caffeine L-ascorbic acid Progesterone Coumarins

⚗️ Ingredient

Cryptoxanthin

Open on HERB 2.0 ↗

Clinical Trials

Meta-Analyses

PubMed References

Top Conditions Studied with Cryptoxanthin

Hypercholesterolemia|Osteoporosis 1 Beta-cryptoxanthin Supplementation 1 The clinical study including cohort study, cross-sectional s 1 Assessment of dietary intake is known to involve a number of 1 Vitamin A Deficiency 1

📋 Sample Trials

NCT05046457

Beta-cryptoxanthin Supplement: Absorption and Function

Completed

NCT02065024

Food Matrix and Genetic Variability as Determinants of Bioavailability and Biological Effects of Beta-cryptoxanthin and Phytosterols

Completed · Phase 1

NCT04153968

Bioefficacy of Beta-cryptoxanthin From Biofortified Maize

Unknown

📊 Sample Meta-Analyses

CRD42020216036

The effect of beta-cryptoxanthin on the risk of osteoporosis and bone fracture of human

The clinical study including cohort study, cross-sectional study, case-control s

CRD42023485956

Assessment of biological carotenoid levels as biomarkers of dietary intake: a systematic review and meta-analysis protocol

Assessment of dietary intake is known to involve a number of challenges and limi

📚 Sample References

None linked yet.

⚗️ All Ingredient data fields for Cryptoxanthin

⚗️ Identity

Name

Cryptoxanthin

Aliases / Synonyms

beta-Cryptoxanthin; 472-70-8; Caricaxanthin; Cryptoxanthine; Cryptoxanthol; beta-Caroten-3-ol; Kryptoxanthin; Neocryptoxanthin; Xanthrophyll 1

🧪 Chemistry

Molecular Weight

552.8870

LogP

11.5766

Drug-likeness

0.267

H-Bond Acceptors

H-Bond Donors

Rotatable Bonds

🔬 Structures

Canonical SMILES

CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(CC(CC2(C)C)O)C)C)C

Isomeric SMILES

CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C2=C(C[C@H](CC2(C)C)O)C)/C)/C

InChIKey

DMASLKHVQRHNES-FKKUPVFPSA-N

InChI

InChI=1S/C40H56O/c1-30(18-13-20-32(3)23-25-37-34(5)22-15-27-39(37,7)8)16-11-12-17-31(2)19-14-21-33(4)24-26-38-35(6)28-36(41)29-40(38,9)10/h11-14,16-21,23-26,36,41H,15,22,27-29H2,1-10H3/b12-11+,18-13+,19-14+,25-23+,26-24+,30-16+,31-17+,32-20+,33-21+/t36-/m1/s1

🔗 External References

HERB DB

HBIN021796 ↗

PubChem CID

5281235 ↗

CAS Number

472-70-8 ↗

NPASS

NPC164487

HIT

C0743

TCMID

23741

TCMSP

MOL009674; MOL003059

TCM-ID

5419

🔍 Raw view — every non-empty column on this row (32 fields)

name

Cryptoxanthin

common names

beta-Cryptoxanthin; 472-70-8; Caricaxanthin; Cryptoxanthine; Cryptoxanthol; beta-Caroten-3-ol; Kryptoxanthin; Neocryptoxanthin; Xanthrophyll 1

herb ingredient id

HBIN021796

canonical smiles

CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(CC(CC2(C)C)O)C)C)C

isomeric smiles

CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C2=C(C[C@H](CC2(C)C)O)C)/C)/C

inchi

inchikey

DMASLKHVQRHNES-FKKUPVFPSA-N

mol wt

552.8870

num h acceptors

num h donors

mol logp

11.5766

num rotatable bonds

drug likeness

0.267

cas id

472-70-8

tcmid ingredient id

23741

tcmsp ingredient id

MOL009674; MOL003059

tcm id ingredient id

5419

pubchem cid

5281235

npass id

NPC164487

hit id

C0743

🏥 Linked Health Topics

1 · studied for these conditions (text bridge)

Vitamin A Deficiency

syndrome

📋 Clinical Trials

3 · subject of clinical study

NCT05046457 Beta-cryptoxanthin Supplement: Absorption and Function

→ Beta-cryptoxanthin Supplementation

NCT02065024 Food Matrix and Genetic Variability as Determinants of Bioavailability and Biolo

→ Hypercholesterolemia|Osteoporosis

NCT04153968 Bioefficacy of Beta-cryptoxanthin From Biofortified Maize

→ Vitamin A Deficiency

📊 Meta-Analyses

2 · systematic review

CRD42020216036 The effect of beta-cryptoxanthin on the risk of osteoporosis and bone fracture o

→ The clinical study including cohort study, cross-s

CRD42023485956 Assessment of biological carotenoid levels as biomarkers of dietary intake: a sy

→ Assessment of dietary intake is known to involve a

How relationships are computed

Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
Herb ↔ Ingredient: empty — needs HERB_herb_ingredient import
Ingredient ↔ Target: empty — needs HERB_ingredient_target import
Target ↔ Disease: empty — needs HERB_target_disease import
Herb → Target → Disease (full chemical spine): awaiting Phase 2e link tables